2001
DOI: 10.1007/s00210-001-0498-6
|View full text |Cite
|
Sign up to set email alerts
|

Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats

Abstract: In anaesthetized rats activation of vanilloid receptors on sensory vagal nerves elicits rapid bradycardia and hypotension (Bezold-Jarisch reflex). Recent in vitro experiments revealed that the endogenous cannabinoid ligand anandamide acts as an agonist at the vanilloid VRI receptors. The present study was aimed at examining whether vanilloid VR1 receptors are involved in the cardiovascular effects of anandamide in the anaesthetized rat. Intravenous injection of anandamide, its stable analogue methanandamide an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

11
130
5
2

Year Published

2003
2003
2021
2021

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 111 publications
(148 citation statements)
references
References 25 publications
11
130
5
2
Order By: Relevance
“…Likewise, anandamide, an endogenous cannabinoid ligand acting on both the VR1 and cannabinoid receptor (CB1), induces similar changes in blood pressure as that of CAP. 17 In the present study, perfusion of CAP at a much lower dose (2.4 nmol) than these previous studies either intravenously or into the left renal pelvis did not alter blood pressure. Whereas CAP at this lower dose given intravenously had no effect on Uflow or UNa, this dose of CAP given into the renal pelvis unilaterally increased bilateral Uflow and UNa, suggesting a pressure-independent and renal pelvis-specific effect of VR1 activation leading to enhancement of renal excretory function.…”
Section: Zhu Et Al Vanilloid Receptor Diuresis Natriuresiscontrasting
confidence: 58%
See 1 more Smart Citation
“…Likewise, anandamide, an endogenous cannabinoid ligand acting on both the VR1 and cannabinoid receptor (CB1), induces similar changes in blood pressure as that of CAP. 17 In the present study, perfusion of CAP at a much lower dose (2.4 nmol) than these previous studies either intravenously or into the left renal pelvis did not alter blood pressure. Whereas CAP at this lower dose given intravenously had no effect on Uflow or UNa, this dose of CAP given into the renal pelvis unilaterally increased bilateral Uflow and UNa, suggesting a pressure-independent and renal pelvis-specific effect of VR1 activation leading to enhancement of renal excretory function.…”
Section: Zhu Et Al Vanilloid Receptor Diuresis Natriuresiscontrasting
confidence: 58%
“…17 It markedly reduces blood pressure with bradycardia presumably evoked by the Bezold-Jarisch reflex (phase I), leading to a brief vasopressor effect (phase II) followed by a prolonged depressor phase (phase III). Likewise, anandamide, an endogenous cannabinoid ligand acting on both the VR1 and cannabinoid receptor (CB1), induces similar changes in blood pressure as that of CAP.…”
Section: Zhu Et Al Vanilloid Receptor Diuresis Natriuresismentioning
confidence: 99%
“…17 Three hours after surgery, baseline MAP and its response to the above-mentioned drugs were determined with the rats fully awake and unrestrained.…”
Section: Methodsmentioning
confidence: 99%
“…Capsazepine and ruthenium red, antagonists of the TRPV 1 receptor, dose-dependently inhibit the phase I bradycardic response in anesthetized rats, without affecting the phase III hypotension, which was abolished by the cannabinoid CB 1 receptor antagonist SR141716 (Malinowska et al, 2001) and was also absent in CB 1 receptor knockout mice (Ledent et al, 1999;Járai et al, 1999).…”
Section: Cardiovascular Effects Of Cannabinoids In Vivo Role Of Cb 1mentioning
confidence: 99%